Thyroid storm and myxedema coma.
This article describes the clinical recognition of, and pathophysiological mechanisms underlying the development of, thyroid storm and myxedema coma. Effective therapeutic management of these conditions depends on a clear understanding of the physiological adaptations occurring in hyperthyroidism and hypothyroidism, and of how precipitating events may produce these decompensated states.
Nicoloff
J T
JT
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D001424:Bacterial Infections / Q000209:etiology; D001833:Body Temperature Regulation; D003128:Coma / Q000150:complications / Q000175:diagnosis / Q000378:metabolism / Q000503:physiopathology; D006801:Humans; D006980:Hyperthyroidism / Q000150:complications / Q000175:diagnosis* / Q000503:physiopathology; D007022:Hypotension / Q000628:therapy; D007037:Hypothyroidism / Q000150:complications / Q000175:diagnosis* / Q000503:physiopathology; D000860:Hypoxia / Q000628:therapy; D009230:Myxedema / Q000150:complications / Q000175:diagnosis* / Q000378:metabolism / Q000503:physiopathology / Q000628:therapy; D013958:Thyroid Crisis / Q000150:complications / Q000175:diagnosis* / Q000188:drug therapy / Q000378:metabolism / Q000503:physiopathology / Q000628:therapy
D000319:Adrenergic beta-Antagonists